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Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease character-
ized by selective loss of motor neurons with inclusions frequently containing the RNA/DNA
binding protein TDP-43. Using a yeast model of ALS exhibiting TDP-43 dependent toxicity,
we now show that TDP-43 overexpression dramatically alters cell shape and reduces ubi-
quitin dependent proteolysis of a reporter construct. Furthermore, we show that an excess
of the Hsp40 chaperone, Sis1, reduced TDP-43’s effect on toxicity, cell shape and proteoly-
sis. The strength of these effects was influenced by the presence of the endogenous yeast
prion, [PIN+]. Although overexpression of Sis1 altered the TDP-43 aggregation pattern, we
did not detect physical association of Sis1 with TDP-43, suggesting the possibility of indirect
effects on TDP-43 aggregation. Furthermore, overexpression of the mammalian Sis1 homo-
logue, DNAJB1, relieves TDP-43 mediated toxicity in primary rodent cortical neurons, sug-
gesting that Sis1 and its homologues may have neuroprotective effects in ALS.
Author summary
Many neurodegenerative diseases are associated with aggregation of specific proteins.
Thus we are interested in factors that influence the aggregation and how the aggregated
proteins are associated with pathology. Here, we study a protein called TDP-43 that is fre-
quently aggregated in the neurons of patients with amyotrophic lateral sclerosis (ALS).
TDP-43 aggregates and is toxic when expressed in yeast, providing a useful model for
ALS. Remarkably, a protein that modified TDP-43 toxicity in yeast successfully predicted
a new ALS susceptibility gene in humans. We now report a new modifier of TDP-43 toxic-
ity, Sis1. We show that expression of TDP-43 in yeast inhibits degradation of damaged
protein, while overexpression of Sis1 restores degradation. Thus suggests a link between
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protein degradation and TDP-43 toxicity. Furthermore we show that a mammalian pro-
tein similar to Sis1 reduces TDP-43 toxicity in primary rodent neurons. This identifies the
mammalian Sis1-like gene as a new ALS therapeutic target and possible susceptibility
gene.
Introduction
Amyotrophic lateral sclerosis (ALS), often referred to as "Lou Gehrig’s Disease", is a progres-
sive neurodegenerative disorder characterized by degeneration and ultimately death of motor
neurons in the brain and the spinal cord [1,2]. The most common pathologic characteristic of
ALS is the formation of cytoplasmic inclusions rich in the transactive response element DNA/
RNA binding protein of 43 kDa (TDP-43) [3–7]. Furthermore, mutations in the gene encod-
ing TDP-43 (TARDBP) cause familial ALS [8–11]. Cytoplasmic TDP-43 inclusions are also
common in the majority of individuals with frontotemporal dementia (FTD) [3,4], suggesting
that ALS and FTD are linked by a common disease mechanism involving TDP-43 mislocaliza-
tion and aggregation.
TDP-43 is an RNA/DNA-binding protein [12,13] that is found in the nucleus under normal
conditions [3,4], and is associated with cytoplasmic stress granules during stress [14]. TDP-43
harbors two RNA Recognition Motif (RRM) domains and a C-terminal glycine-rich region,
where most of the ALS-linked mutations are found [12,13,15]. An algorithm to identify
human proteins with aggregation prone, prion-like domains ranked TDP-43 69th among the
entire human proteome, because of its C-terminus (residues 277–414) ([16] also see [17–19]).
The abnormal localization of wild-type or mutant versions of this protein to cytoplasmic foci
in the absence of stress is associated with ALS [3,5,6,20].
Prions are self-seeding conformational variants of particular proteins [21]. The conversion
of largely α-helical cellular prion protein PrPC into self-seeding fibrous β-sheet-rich ordered
aggregates (amyloids) called PrPSc (associated with scrapie) is the causative agent of prion dis-
eases in mammals [22]. A conformational change of a disease-specific soluble cellular protein
to an aggregated form that seeds further aggregation was also shown for Alzheimer’s disease,
Parkinson’s disease and ALS [17,18,23–25].
In addition, several yeast proteins have been shown to convert from soluble to self-seeding
amyloid conformations called prions, and are associated with transmissible phenotypes in
yeast [21,26–33]. Interestingly, yeast prions can enhance the rate of de novo aggregation of het-
erologous prion proteins, presumably by a cross-seeding mechanism. Indeed, the endogenous
yeast prion, [PIN+] [29,34], is required for the aggregation and toxicity of human Huntington’s
disease Htt protein with an expanded polyglutamine (polyQ) tract when expressed in yeast
[35,36].
Chaperones, including Sis1, an Hsp40 chaperone, are required for the propagation of yeast
prions [37–42]. In addition to its high nuclear concentration, Sis1 is also diffusely localized in
the cytoplasm in exponentially growing cells [43]. However, when prion or other amyloid
cytoplasmic aggregates are present, Sis1 also co-localizes with them creating cytoplasmic Sis1
foci [44,45]. Sis1 is required for the fragmentation of prion oligomers. Indeed, reduced or
overexpressed levels of Sis1 lead to larger or smaller prion oligomers [37–41]. The new aggre-
gate ends created by this fragmentation are required for prion propagation. Furthermore, the
smaller aggregates created by fragmentation are more easily transmitted to daughter cells, also
promoting prion propagation [45–47].
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Overexpression of Sis1 rescues yeast from toxicity associated with overexpression of several
prion or prion-like proteins. For example, overexpression of Sis1 reduces [PIN+] dependent
polyQ aggregation and toxicity [48]. The mechanism of rescue is in part because the polyQ
aggregates sequester Sis1, inhibiting it from its normal role of transporting ubiquitinated mis-
folded proteins in the cytoplasm to the nucleus for proteasomal degradation [44].
Similarly, overexpression of Sis1 rescues cells from [PIN+] dependent toxicity of an overex-
pressed prion-like protein Pin4C. When overexpressed in the presence of [PIN+], Pin4C
formed large hyperphosphorylated aggregates that co-localized with Sis1 and reduced degrada-
tion of a ubiquitin proteasome system (UPS) reporter protein. Aggregation, hyperphosphory-
lation and toxicity were suppressed by overexpression of Sis1 [45,49].
Overexpression of Sis1 also rescues [PIN+] dependent toxicity caused by overexpression of
the [PIN+] prion protein, Rnq1. Here, overexpressed Sis1 appears to enhance aggregation of
toxic detergent soluble Rnq1 oligomers into apparently non-toxic larger detergent resistant
aggregates in the nucleus [50,51].
Yeast is a useful organism to study the conversion of soluble disease-specific protein into
amyloid or prion-like aggregates [35,48,52–56]. Overexpressed human TDP-43 forms cyto-
plasmic aggregates in yeast associated with toxicity [53]. Both wild-type TDP-43, which accu-
mulates in the majority of sporadic ALS, and mutant TDP-43, associated with familial ALS,
elicit cell death when overexpressed. However, at near-endogenous expression levels mutant
TDP-43 is significantly more toxic than wild-type TDP-43 [57] consistent with the near com-
plete penetrance of TARDBP mutations in familial ALS [8].
Unlike most other prion-like aggregating proteins, TDP-43 aggregates do not appear to be
typical amyloids [58]. Unbiased screens for overexpression or deletion modifiers of TDP-43
toxicity identified numerous yeast proteins as candidates for involvement in the TDP-43 toxic-
ity cascade. The identification of one such modifier, Pbp1, with a human homologue ATXN2,
led to the discovery that the length of polyglutamine expansions in ATXN2 is associated with
increased risk for ALS [59]. This clearly established the power of the yeast model in under-
standing human disease.
Here, we identify a new modifier by showing that excess Sis1 reduces the toxicity of overex-
pressed TDP-43. Likewise, overexpression of the mammalian Sis1 homologue, DNAJB1,
reduces TDP-43-mediated toxicity in primary rodent cortical neurons, suggesting that Sis1
and its homologues may have neuroprotective effects in ALS. Finally, we provide evidence that
TDP-43 impedes the UPS-mediated degradation of cytosolic misfolded proteins and that over-
expression of Sis1 restores degradation even in the presence of excess TDP-43.
Results
Overexpression of TDP-43 causes altered cell morphology
Although overexpressed polyQ or Pin4C only form large aggregates and causes toxicity in
[PIN+] cells [35,49], overexpressed TDP-43 does so in both [PIN+] and [pin-] yeast [53,60].
Likewise, we saw that overexpressed TDP-43 inhibited growth in both [PIN+] and [pin-] cells
(Fig 1A and S1 Fig). Although we noted some variability between transformants and strain
backgrounds, there was often a slightly stronger inhibition in [PIN+] vs. isogenic [pin-] cells
(Fig 1A).
In addition, we found that overexpressed TDP-43 altered cell shape, and again the effect
was slightly but reproducibly stronger in [PIN+] cells. We examined this effect in three strain
backgrounds for cells grown on 2% galactose plates for 4 days (S2 Fig). In strain 74D-694
[PIN+] nearly every cell showed altered morphology, with less extreme numbers and less elon-
gation in [pin-] cells. Elongated cells were also easily seen in BY4741 and W303 strain
Sis1 Chaperone and TDP-43 toxicity
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Fig 1. Overexpression of TDP-43 causes growth inhibition and altered cell morphology, both of which are partially
relieved by overexpression of the Sis1 Hsp40 chaperone. (A) TDP-43 growth inhibition is more extreme in [PIN+] 74D-694
cells and is partially relieved by Sis1 overexpression. [PIN+] (L1749) and [pin-] (L2910) cells transformed with pGAL1-TDP-
43-YFP (p2042), or pYFP control (p1752) and pGAL1-SIS1 (p1767), or empty control (p1768) plasmids, were selected on
SD-Ura-Trp plates. Normalized suspensions of cells taken from SD-Ura-Trp were 10X serially diluted in water and 15 μl were
Sis1 Chaperone and TDP-43 toxicity
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backgrounds although especially in BY4741 many cells did not have an altered shape. Likewise,
74D-694 overexpressing TDP-43 for 24 h in liquid were elongated and bloated relative to con-
trol cells without TDP-43 overexpression (Fig 1C and 1D). Using cells with the endogenous
nuclear Htb1 protein tagged with mCherry [61], we could see that the bloated/elongated cells
each have only one non-fragmented nucleus and so did not result from a failure of cytokinesis
(Fig 2). Finally, the cell morphological change was proportional to the TDP-43 expression level
(S3 Fig).
Overexpression of the Hsp40 chaperone, Sis1, relieves effects of TDP-
43 on cell toxicity and shape
Since overexpression of Sis1 suppressed toxicity of other overexpressed aggregating proteins
(polyQ, Rnq1 and Pin4C) [44,49–51] we decided to look at the effect of Sis1 on TDP-43 toxic-
ity even though previous screens for modifiers of TDP-43 and FUS toxicity in yeast did not
uncover Sis1 [54,59,62].
We compared growth of cells overexpressing TDP-43-YFP with those co-overexpressing
Sis1 and TDP-43-YFP. Excess Sis1 reduced growth inhibition due to TDP-43 in both [pin-]
and [PIN+] cells in three strain backgrounds. The rescue appeared to be weaker in 74D-694
[PIN+] cells where TDP-43 is more toxic (Fig 1A). While overexpression of Sis1 did not
completely suppress TDP-43 toxicity, it altered TDP-43 toxicity more efficiently than previ-
ously reported modifiers of TDP-43 toxicity: overexpression of Hsp104, Pbp1 or human Upf1
[59,63–65] (S1 Fig).
Overexpression of Sis1 also reduced cell death (Fig 1B) and the level of cell bloating/elonga-
tion associated with TDP-43 overexpression (Figs 1D and 2). Sis1 overexpression did not
cause these effects by reducing the level of TDP-43 or by curing cells of [PIN+], because TDP-
43 levels remained unchanged (Fig 3) and Sis1 overexpression does not cure cells of [PIN+]
[66] (S4 Fig).
TDP-43 overexpression inhibits the degradation of a UPS reporter
protein and overexpression of Sis1 reverses this effect
Previous results showed that overexpression of polyQ or Pin4C in [PIN+] cells reduced degra-
dation of a UPS reporter, CG [44,49], and that the overexpression of Sis1 reversed this polyQ
effect [44,49]. Thus we asked if TDP-43 overexpression likewise affects clearance of CG. CG
is the mutant version of the secretory protein carboxypeptidase Y lacking its signal sequence
and tagged with GFP (ΔssCPY). Normally, CG is rapidly degraded via the UPS, dependent
on Hsp40 and Hsp70 chaperones [44]. After inhibition of new protein synthesis with cyclohex-
imide (CHX), CG degradation was inhibited by TDP-43 overexpression (Fig 4). The effect
was seen in both [pin-] and [PIN+] 74D-694 cells but was more dramatic in [PIN+] cells where
TDP-43 is more toxic. Furthermore, simultaneous overexpression of Sis1 and TDP-43 resulted
spotted on SD-Ura-Trp (dextrose), and 2% Gal-Ura-Trp (galactose) plates, which were photographed after 3 (dextrose) or 5
(galactose) days of incubation at 30˚C. (B) Sis1 overexpression partially rescues cells from death caused by TDP-43
overexpression. Viability of [pin-] cells transformed with pGAL1-TDP-43 (p2195), or control (p2186) and pGAL1-SIS1 (p1759), or
control (p484) plasmids and grown for 72 h on 2% raffinose + 2% galactose selective media was determined by staining dead
cells with trypan blue. Shown is the average and standard error from three separate experiments. (C) TDP-43 overexpression
causes cell elongation, which is more extreme in [PIN+] cells. Cells transformed with pGAL1-TDP-43 (p2055) or control (p484)
were grown overnight in liquid SRaf-Ura, and galactose was added to induce TDP-43 expression for 24 h prior to imaging. (D)
Sis1 overexpression partially relieves cell elongation caused by TDP-43-YFP overexpression both in [pin-] and [PIN+] cells. Cells
co-transformed with pGAL1-TDP-43-YFP (p2042), or control (p1752) and pGAL1-SIS1 (p1767), or control (p1768) plasmids on
SD-Ura-Trp were grown overnight in liquid SRaf-Ura-Trp to OD600: 0.5 to 0.7. Galactose was added to 2% to induce TDP-
43-YFP and cells were imaged following fixation at 24 h.
https://doi.org/10.1371/journal.pgen.1006805.g001
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in rapid degradation of CG. This is consistent with the hypothesis that TDP-43 toxicity in
part results from interference with the UPS system.
Since deletion of HSP104 prevents propagation of several yeast prions [21] we looked for
effects of hsp104Δ on the ability of Sis1 overexpression to reduce TDP-43 toxicity. No effects
were detected when comparing cells with wild-type HSP104 vs. hsp104Δ (S5A Fig). Also, as
Sis1 is an Ssa1 co-chaperone [67,68] we looked for effects of lowered Ssa1 activity on the ability
of Sis1 overexpression to reduce TDP-43 toxicity. This experiment was complicated by the fact
that in addition to Sis1 being a co-chaperone for Ssa1, it is presumed to be a co-chaperone of
the other members of the Ssa family (Ssa2, Ssa3 and Ssa4). Furthermore, deletion of all mem-
bers of this family is lethal and deletion of one member is compensated for by alteraed expres-
sion of other members. Thus, we used the dominant negative SSA1-21mutant in an ssa2Δ
background which has a dramatic effect on Ssa family activity causing loss of the [PSI+] prion
[69]. We found that this alteration in Ssa activity did not detectably affect the ability of Sis1
overexpression to reduce TDP-43 toxicity (S5B Fig).
Fig 2. Cells elongated due to TDP-43-GFP expression retain single nuclei. [PIN+] (L3491) and [pin-] (L3496) cells with nuclei marked with
HTB1-mCherry were co-transformed with controls pGAL1-GFP (p1764) and pGAL1 empty vector (p1768) “GFP/ v”, control and pGAL1-Sis1 (p1767)
“GFP/ Sis1”, pGAL1-TDP-43-GFP (p2288) and control “TDP-43-GFP/ v” and “TDP-43-GFP/ Sis1”. Transformants were cultured in SD-Ura-Trp medium
to OD600 0.5 and re-inoculated into SGal/Raf-Ura-Trp containing 0.5% raffinose and 2% galactose to induce TDP-43-GFP and Sis1. Cells were fixed at
24 h and imaged.
https://doi.org/10.1371/journal.pgen.1006805.g002
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TDP-43 forms sarkosyl resistant aggregates that are not affected by
Sis1 overexpression
TDP-43 aggregates are soluble in 2% SDS at room temperature and to fail to stain with the
amyloid dye thioflavin T [53]. We asked if the TDP-43 aggregates had the amyloid-like prop-
erty of being insoluble in a different detergent, sarkosyl, because some pathological TDP-43
aggregates were resistant to sarkosyl [3,4] and because in vitro fibrillized TDP-43 remains
insoluble in sarkosyl [70]. Indeed, when we treated lysates of cells harboring TDP-43 aggre-
gates with sarkosyl at room temperature (Fig 3), TDP-43-YFP oligomers were visible in
unboiled samples. The size and abundance of these oligomers was unchanged by Sis1 overex-
pression and Sis1 was not detected in these oligomers.
Fig 3. TDP-43 aggregates form sarkosyl-resistant oligomers that are not affected by Sis1 overexpression. TDP-43 aggregates form sarkosyl-
resistant oligomers. [PIN+] cells (L1749) expressing GAL1-regulated TDP-43-YFP (p2042) or TDP-43-GFP (p2288) and GAL1-regulated SIS1 (p1767)
or empty control (p1768) plasmids, were grown on 2% Gal for 24 h. Proteins were then extracted and treated with 2% sarkosyl for 7 minutes (unboiled)
or, to visualized monomers, were boiled for 5 minutes with 2% SDS with DTT (boiled). Proteins were resolved in a 1.5% agarose semi-denaturing gel
(SDD-AGE) and visualized with an anti-TDP-43 antibody. As a positive control, [PSI+] oligomers were also visualized using an anti-Sup35C antibody
(BE4, mouse monoclonal against Sup35C). After TDP-43-GFP detection, the membrane was stripped and reprobed with Sis1 antibody (kind gift of E.
Craig). Protein size markers were from BioRad. TDP-43-GFP or -YFP and Sis monomer are respectively ~70 and 39.5 kDa. In unboiled samples, Sis1
runs as a dimer.
https://doi.org/10.1371/journal.pgen.1006805.g003
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Fig 4. TDP-43 overexpression inhibits degradation of a UPS-reporter and co-expression of Sis1 restores that degradation. Degradation
of CG*, the mutant version of the secretory protein carboxypeptidase Y lacking its signal sequence tagged with EGFP (ΔssCPY*) was used to
report functionality of the ubiquitin proteasome system (UPS). Levels of CG*were determined in cell lysates [103] harvested at 0, 30, 90 and 180
minutes following inhibition of new protein synthesis with cycloheximide. [pin-] (L2910) or [PIN+] (L1749) cells expressing GAL1 regulated CG*-
EGFP (p2154) and either control empty vectors (p2039, p1768) “v / v”; TDP-43 (p2055) and control “TDP-43 / v”; or TDP-43 and Sis1 (p1767)
“TDP-43 / Sis1”, were grown in liquid SR-Trp-Ura-His to OD 600 0.7. Galactose to 2% was added and cells were grown for 24 h to induce TDP-
43, Sis1 and CG* expression. Protein synthesis was then inhibited with 0.75 ([pin-]) or 0.5 ([PIN+]) μg/ml cycloheximide for the times indicated. (A)
Sis1 Chaperone and TDP-43 toxicity
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Overexpression of Sis1 alters, but does not inhibit TDP-43 aggregation
Not only does overexpression of Sis1 inhibit toxicity of polyQ and Pin4C but it also dramati-
cally reduces aggregation of these proteins [44,49]. In contrast, TDP-43 formed large aggre-
gates even in the presence of overexpressed Sis1. However, the frequency of small aggregates
was influenced by the level of Sis1: when the level of Sis1 was reduced, TDP-43-YFP formed
more smaller aggregates that appeared in addition to larger aggregates that were comparable
in size and number to that seen with the higher level of Sis1 (Fig 5A). In this experiment, Sis1
expression was controlled via a TET promoter, whereby the level of Sis1 was above normal in
the absence of doxycycline and below normal in the presence of doxycycline. In control cul-
tures with endogenous Sis1 but no TET controlled Sis1 (GF820), aggregation patterns of over-
expressed TDP-43-YFP were not affected by doxycycline.
Despite the above aggregation pattern differences, no reproducible differences were seen in
the level of soluble vs. insoluble TDP-43 in the presence or absence of Sis1 overexpression.
About 55–60% of TDP-43 was found in the pellet whether or not Sis1 was overexpressed (Fig
5B).
There is no direct evidence for a physical association between Sis1 and
TDP-43 aggregates
The finding that the essential chaperone, Sis1, is sequestered by PolyQ and Pin4C aggregates
suggested that the lack of functional Sis1 could contribute to PolyQ and Pin4C-mediated toxic-
ity [45,49]. We thus asked if the aggregates formed by overexpression of TDP-43-GFP co-
localized with endogenous Sis1 tagged with mCherry (Sis1-mCh). Sis1-mCh is largely diffuse
in the nucleus but also forms some cytoplasmic dots [71,72]. However, TDP-43-GFP and
Sis1-mCh dots failed to show any co-localization (Fig 6A). We also investigated the interaction
of Sis1 and TDP-43 with co-immunocapture. Sis1 failed to associate with TDP-43-GFP cap-
tured with TDP-43 antibody (Fig 6B).
DNAJB1 overexpression, but not reduction, modifies TDP-43 toxicity in
primary neurons
There are many Hsp40 chaperones with distinct structures and functions in mammalian cells
[73]. One of these proteins, DNAJB1, has the most similarity to the yeast Sis1. To determine if
DNAJB1 extended neuronal survival in mammalian neurons, we overexpressed wild-type
(WT) and mutant TDP-43 (A315T) linked with familial ALS in rodent primary cortical neu-
rons [8,57]. This model recapitulates several features of human disease, including neurodegen-
eration, the formation of ubiquitin-positive neuronal aggregates, and cytoplasmic TDP-43
mislocalization in affected cells [3,57]. For these assays, individual neurons expressing WT or
mutant TDP-43-EGFP or EGFP alone were monitored at regular intervals for 10 days by fluo-
rescence microscopy, and the time of death for each cell used to create survival or cumulative
hazard plots (Fig 7A and 7B). Both WT and mutant TDP-43-EGFP were highly toxic when
overexpressed, effectively doubling the risk of death over that of control neurons transfected
with EGFP (hazard ratio (HR) 2.02 and 2.06, respectively, p< 2x10-16, Cox hazards analysis).
Although DNAJB1 expression caused mild toxicity in control neurons (HR 1.24, p = 0.0001),
it also extended the survival of neurons transfected with TDP-43(A315T) by 15% (HR 0.85
A representative Western blot. Normalized cell lysates were run on SDS-PAGE followed by immunoblotting with anti-GFP (1:5,000, Roche) for
CG*-EGFP level and anti-Pgk1 (1:10,000, Novex) as an internal loading control. (B) Quantification of three blots showing normalized ratio of CG*-
EGFP and Pgk1. Standard error for three blots is shown.
https://doi.org/10.1371/journal.pgen.1006805.g004
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compared to TDP-43(A315T)-EGFP alone, p = 0.001). In contrast, DNAJB1 co-expression
had no significant effect upon TDP-43(WT)-EGFP expressing cells (HR 0.98 compared to
TDP-43(WT)-EGFP alone, p = 0.7). Since TDP-43 levels are directly proportional to survival
[74], we questioned whether DNAJB1 expression may affect neuronal survival by acting on
TDP-43(A315T) levels. However, we detected no significant alterations in TDP-43(WT)-
EGFP or TDP-43(A315T)-EGFP levels associated with DNAJB1 expression (Fig 7C). Thus, as
in yeast, expression of DNAJB1 partially mitigates TDP-43-dependent toxicity.
To determine if deficiencies in DNAJB1 may potentiate neurodegeneration due to the accu-
mulation of TDP-43, we used siRNA to knockdown DNAJB1 in rodent primary cortical neu-
rons overexpressing TDP-43(WT)-mApple or mApple alone (S6 Fig). Similar to its effects
Fig 5. Depletion of Sis1 affects TDP-43 aggregation without causing a significant difference in TDP-43
soluble vs. aggregated distribution. W303 [PIN+] cells with a deletion of SIS1 and carrying pCM184-TETR-
SIS1 (Y2182) transformed with GAL1 regulated YFP (p2042) or GFP tagged (p2288) TDP-43, were grown on
plasmid selective 2% dextrose plates. (A) Lowering Sis1 expression level alters the TDP43-YFP aggregation
pattern. Transformants inoculated into 2% raffinose + 2% galactose liquid selective medium were immediately
aliquoted into two tubes. Doxycycline (10 μg/ml) was added to only one such tube to inhibit Sis1 expression
(DOX +). Cells without doxycycline (DOX -) had overexpressed Sis1 levels. After 24 h, both cultures had big
dots, but cultures with reduced Sis1 had more small fluorescent dots than cultures with overexpressed Sis1.
The differences in predominant fluorescent aggregate types were obvious enough by eye that three
investigators were able to distinguish cultures with and without lowered Sis1 blind in more than 6 independent
subclones of pTDP-43-YFP transformants. (B) TDP-43-GFP remains largely in the pellet at low and high Sis1
levels. Transformants selected on SD-Ura without doxycycline were inoculated into SRaf/Gal-Ura either
without doxycyline (DOX -) to induce TDP-43-GFP with a high level of Sis1, or with 8.5 μg/ml doxycycline, to
induce of TDP-43-GFP while depleting Sis1 (DOX +). Cells were harvested at 24 h and lysed. Total (T),
supernatant (S) and pellet (P) fractions from lysates were separated by centrifugation at 90,000 rpm for 30
min, resolved with PAGE and immunoblotted with anti-TDP-43 antibodies. Membranes were stripped and
reprobed with anti-Sis1 antibodies, and as a control, anti-Pgk1 antibodies for soluble proteins.
https://doi.org/10.1371/journal.pgen.1006805.g005
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when overexpressed, DNAJB1 knockdown increased the risk of death by 20% in control neu-
rons expressing mApple alone (HR 1.2 compared to scrambled siRNA, p 0.004). Knockdown
of DNAJB1 likewise enhanced the risk of death by 21% in neurons overexpressing TDP-43
(WT)-mApple (HR 1.21 compared to scrambled siRNA, p = 2.3x10-5). These results show that
DNAJB1 is essential for maintaining neuronal health, and despite the fact that DNAJB1 can
help prevent TDP-43 mediated neurotoxicity, its deficiency does not exacerbate neurodegen-
eration due to TDP-43 overexpression.
Discussion
Aggregation of TDP-43 is frequently associated with ALS and other neurological diseases [75–
79] and overexpressed human TDP-43 is toxic and forms cytoplasmic aggregates in yeast and
Fig 6. Sis1 and TDP-43 are not physically associated. (A) Cytoplasmic aggregates formed by
Sis1-mCherry and TDP-43-GFP appear to be independent. [PIN+] cells with endogenous Sis1 tagged with
mCherry (L3478) were transformed with pGAL1-TDP-43-GFP (p2288). Galactose to 2% was added to cells
grown overnight in 2% raffinose and cells were imaged after 4 h in the mCherry and GFP channels. GFP and
mCherry dots (arrow heads) failed to show co-localization. (B) Immunocapture of overexpressed TDP-
43-GFP did not co-capture endogenous Sis1. The interaction between TDP-43-GFP (p2288) and
endogenous Sis1 was assayed in [pin-] (L2910) and [PIN+] (L1749) cells. Lysates (Input) made after 24 h
growth in SRaf/Gal-Ura medium to induce TDP-43-GFP were incubated with (TDP-43) or without (control)
anti-TDP-43 antibodies. Material bound to the antibody was collected with magnetic beads with immobilized
G-protein. Following wash, bound proteins were eluted and analyzed by electrophoresis and immunoblotting.
The same membrane was immunoblotted with anti-TDP-43 antibodies, then reprobed with anti-Sis1 and anti-
Pgk1 antibodies.
https://doi.org/10.1371/journal.pgen.1006805.g006
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mammalian neurons [53,59,64,65]. Our finding in yeast that TDP-43 aggregates inhibit clear-
ance of a misfolded reporter protein, CG by the ubiquitin proteasome system (UPS) [80], is
consistent with the hypothesis that some of the TDP-43 associated toxicity is caused by proteo-
lytic dysfunction. Indeed, failure of proteolysis and the consequent accumulation of misfolded
proteins is associated with a variety of diseases [23,24,44]. Furthermore, we found that the
Fig 7. Mammalian DNAJB1 relieves TDP-43 toxicity in primary cortical neurons. Primary rodent cortical neurons were
transfected with mApple, and TDP-43(A315T)-EGFP, TDP-43(WT) or EGFP. They were also co-transfected with DNAJB1 or
empty vector. (A) Images used to calculate time of death. Cells were imaged at repeated intervals using longitudinal fluorescence
microscopy. Time of death (red dotted circles) was estimated conservatively as the last time a neuron was seen alive. Scale bar,
25 μm. (B) Cumulative risk of death plot. While DNAJB1 displays some toxicity in control neurons when overexpressed, it also
reduces the risk of death in neurons expressing TDP-43(WT)-EGFP or TDP-43(A315T)-EGFP. *p < 0.005; ** p < 2x10-16, by Cox
proportional hazards analysis. Results were pooled from three independent experiments. (C) Overexpression of DNAJB1 does not
significantly alter the expression of TDP-43. Levels of TDP-43-EGFP and TDP-43(A315T)-GFP were determined in the presence
of the plasmid expressing DNAJB1 and the empty vector control, by measuring GFP intensity. Using one-way ANOVA with Tukey’s
test to compare all groups, DNAJB1 expression does not have a significant effect on TDP-43-EGFP levels.
https://doi.org/10.1371/journal.pgen.1006805.g007
Sis1 Chaperone and TDP-43 toxicity
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006805 May 22, 2017 12 / 26
effect of TDP-43 on toxicity is correlated with its effect on UPS: TDP-43 is more toxic in
[PIN+] than [pin-] 74D-694 cells and likewise has a greater effect on UPS in [PIN+] vs. [pin-]
cells. By analogy, the presence vs. absence of heterologous aggregates in mammalian cells may
also influence the proteostasis of disease-causing aggregates.
Why and how [PIN+] effects toxicity and UPS inhibition is unknown. While [PIN+] dra-
matically enhances aggregation and toxicity of polyQ and Pin4C [44,49], the visible appear-
ance of TDP43 aggregates formed in [PIN+] vs. [pin-] cells are indistinguishable. Nonetheless,
the fact that [PIN+] prion aggregates sequester some essential chaperones including Sis1 [66]
could make [PIN+] cells more vulnerable to TDP-43 overexpression, e.g. the lower level of Sis1
available for the UPS in [PIN+] cells could make cells more sensitive to the inhibitory effect of
TDP-43 on the UPS. Indeed, we found that overexpression of Sis1 reduces the deleterious
effects of TDP-43 on cell growth, cell shape and UPS inhibition. Several genetic screens in
yeast have identified modifiers of TDP-43 toxicity; however, Sis1 was not among them
[59,62,81]. The importance of such screens was clearly established when one such modifier,
Pbp1, led to the discovery of a new human ALS risk factor, ATXN2 harboring intermediate
length polyglutamine expansions, the human homolog of yeast Pbp1 [59]. Sis1 may have been
missed in the overexpression screens because of their high throughput nature. Although the
Sis1 effect was weak in the strains used, it was at least as strong as that of several other modifi-
ers that were detected (Hsp104, Pbp1 and hUpf1) (S1 Fig). Since the presence or absence of
[PIN+] and other unknown differences between strains alter the toxicity of TDP-43, repeating
screens for toxicity modifiers in additional yeast strain backgrounds may reveal new
modifiers.
The mechanism by which overexpression of Sis1 rescues TDP-43 toxicity is unknown. Sis1
has a C-terminal substrate binding domain, an N-terminal J domain that regulates the ATPase
activity of Hsp70, and a dimerization domain at the end of its C-terminus. It is largely in the
nucleus, but is involved with other proteins in nucleocytoplasmic shuttling that transports ubi-
quitinated proteins to the nucleus for degradation by the proteasome [44]. When cells are sub-
jected to stress, cytoplasmic diffuse Sis1 accumulates in juxtanuclear and peripheral punctate
compartments [71], as well as in stress granules, which it helps target for autophagy [72].
Overexpression of Sis1 also rescues yeast from toxicity and inhibition of UPS associated
with amyloid aggregates formed upon overexpression of polyQ or Pin4C [44,49]. However,
unlike for TDP-43, in these cases Sis1 clearly co-localizes with the aggregates, suggesting that
inhibition of Sis1 activity is the source of the toxicity and/or that Sis1 renders the aggregates
non-toxic. Indeed, in these cases overexpression of Sis1 inhibits aggregate formation. In con-
trast, TDP-43 formed large aggregates independently of the Sis1 level, although there were also
numerous small TDP-43 aggregates at reduced levels of Sis1. Possibly Sis1 helps to shear small
TDP-43 aggregates so that with lower levels of Sis1 the smaller aggregates continue to grow
without being sheared and become visible.
In addition, Sis1 overexpression rescues cells from toxicity associated with overexpression
of Rnq1 in [PIN+] cells [50]. In that case, Sis1 overexpression caused a reduction in small solu-
ble RnqQ1 oligomers that were presumed to be the toxic species. Also, Sis1 has been shown to
help shear prion aggregates reducing the size of their detergent resistant oligomers
[37,38,66,71]. No such effects of Sis1 on TDP-43 oligomer size were detected in our study.
Thus, the mechanism by which Sis1 rescues cells from TDP-43 toxicity appears to be dis-
tinct from its rescue of polyQ, Pin4C or Rnq1 toxicity. Previous studies implicated a direct
effect of a different HSP40 chaperone, DNAJB6 (a member of the DNAJB7 and 8 family) on
TDP-43 via interactions with the TDP-43 C-terminal domain [82,83]. In contrast, we did not
detect any direct interaction between TDP-43 and Sis1 (homolog of DNAJB1 and part of the
B2, B4, B5, B9 and B11 HSP40 family). Possibly TDP-43 causes toxicity and inhibits UPS for
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reasons unrelated to Sis1. Overexpression of Sis1 could still rescue by enhancing UPS through
an independent mechanism. In support of this hypothesis, Sis1 overexpression in the presence
of TDP-43 enhanced UPS activity above that seen in cells without TDP-43 (Fig 4).
Our findings that overexpression of the human homolog of Sis1, DNAJB1, reduced TDP-
43 A315T toxicity in primary cortical neurons suggests that the mechanism by which Sis1
reduces cell death is conserved. Indeed, other Hsp40 chaperones have also been reported to
affect the cellular formation of amyloid protein aggregates in mammalian cells [83–87]. The
magnitude of the Sis1 effect seen here is similar to that seen with other genetic modifications
(i.e. DBR1 knockdown) [88].
Mutations in different Hsp40 family member, DNAJB6, have been shown to cause limb-gir-
dle muscular dystrophy (LGMD) and to inhibit induced nuclear and cytoplasmic TDP-43
aggregation induced by stress, although no effect on toxicity was found [82,83,89]. Our new
results show that Sis1 (and in neurons its mammalian homolog, DNAJB1) reduces toxicity
arising from TDP-43 accumulation, and furthermore, this occurs in the absence of a direct
stressor such as heat. It remains to be determined if the protection afforded by Sis1, and
DNAJB1 in mammalian cells, can be an effective means of extending neuronal survival in ALS
and in related conditions characterized by cytoplasmic mislocalization and aggregation of
DNA/RNA binding proteins such as TDP-43.
Methods
Strains and plasmids
Yeast strains and plasmids used in this study are listed in Tables 1 and 2, respectively. In L3478
the C-terminus of SIS1 was endogenously tagged with mCherry by screening L1749
Table 1. Yeast strains used in this study.
Strains Description Reference
74D-
694
MATa ade1-14 ura3-52 leu2-3,112 trp1-289 his3-200 [91]
L2910 74D-694 [psi-] [pin-] [91]
L1749 74D-694 [psi-] [PIN+] [91]
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
L3270 BY4741 [psi-] [PIN+] [91]
L3269 BY4741 [psi-] [pin-] [91]
L2389 74D-694 [psi-] [pin-], hsp104::LEU2 [91]
L3478 74D-694 [psi-] [PIN+] SIS1-mCherry::HIS5 This study
L3497 [pin-] version of L3478 This study
L3491 74D-694 [psi-] [PIN+] HTB1-mCherry::LEU2 This study
L3496 [pin-] version of L3491 This study
GF820 W303 [PIN+] MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade1-14 his3-
11,15
From S. Lindquist,
MIT
Y2182 W303 [PIN+] sis1Δ::LEU2 pTETR-SIS1 [37]
L3375 [pin-] version of GF820 This study
1001 MATα kar1-1 SUQ5 ade2-1 his3-202 leu2-1 trp1-63 ura3-52 [PSI+] [92]
1014 MATα kar1-1 SUQ5 ade2-1 his3-202 leu2-1 trp1-63 ura3-52 SSA1-21
ssa2Δ [psi-]
[92]
L3504 [psi-] version of 1001 This study
64D-
694
MATa adel-l4 trpl-289 leu2-3,112 ura3-52 lys9-A21 [34]
L2642 64D-694 MATα ade1-14 ura3-52 leu2-3,112 trp1-289 lys9-A21 [psi-] [pin-] [34]
https://doi.org/10.1371/journal.pgen.1006805.t001
Sis1 Chaperone and TDP-43 toxicity
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006805 May 22, 2017 14 / 26
Table 2. Plasmids used in this study.
Plasmids Description Reference
p484 pYES2-GAL (URA3) [50]
p1331 pCM184-TETR (HIS3) [93]
p1369 pRS316-GAL1-SSA1 (URA3) From S. Lindquist, MIT
p1752 pRS416-GAL1-YFP (URA3) [50]
p1759 pYES2-GAL-SIS1 (URA3) [50]
p1764 pAG416 GAL1-ccdB-GFP (URA3) Addgene plasmid 14195
p1767 pYES3-GAL-SIS1 (TRP1) [50]
p1285 pRS316 GAL1-HSP104 (URA3) From S. Lindquist, MIT
pBYO11 Yeast Gateway expression vector with ARS1, CEN4, Gal1-10 promoter (URA3) From S. Lindquist, MIT
p2228 pBYO11 GAL1-PBP1 (URA3) From A. Gitler, Stanford Univ.
p1369 pBYO11 GAL1-SSA1 (URA3) From S. Lindquist, MIT
p2292 pYES2ct / hUPF1 (URA3) [53,54]
p1768 pYES3-GAL (TRP1) [50]
p2039 pAG426 GAL1-ccdB (URA3) Addgene plasmid 14155
p2041 pRS426 GAL1-TDP43-GFP Addgene plasmid 27467
p2042 pRS416-GAL1-TDP-43-YFP (URA3) Addgene plasmid 27447 [60]
p2055 pAG426-GAL1-TDP-43 (URA3) This study
p2368 pAG415-GAL1-TDP-43 (LEU2) This study
p2275 pAG414-GAL1-TDP-43 (TRP1) This study
p2173 pAG415-GAL1-TDP-43-DsRed (LEU2) This study
p2245 pAG415 GAL1-ccdB (LEU2) Addgene plasmid 14145
p2154 pRS413-GAL-ΔssCPY*-GFP (pGAL-CG*) (HIS3) [44]
p2273 pDONR221-TDP-43 with stop codon This study
p2367 pDONR221-TDP-43 with no stop codon This study
p2187 pDONR221-TDP-43-YFP Addgene plasmid 27470
p2186 pAG413-GAL1-ccdB (HIS3) Addgene plasmid 14141
p2189 pAG414-GAL1-ccdB (TRP1) Addgene plasmid 14143
p2302 pAG415-GAL1-ccdB-DsRed (LEU2) Addgene plasmid 14361
p2195 pAG413-GAL1-TDP-43-YFP (HIS3) This study
p1185 CUP1-RNQ1-GFP (TRP1) [90]
p1576 pCM184 Gateway expression vector with TETR This study
p2223 pTETR -TDP-43-YFP This study
p2201 eIF4A [61]Harvard Plasmid Repository (HsCD00412730
p2203 pCNA-DNAJB1-V5 [94]
p2218 pCM184-TETR-SIS1 (TRP1) [37]
p2268 pGW1-mApplepFA6a-link-mCherry-HIS5 Addgene plasmid 44643 [95]
p2278 pRS305-ADH1-HTB1-mCherry (LEU2) [61]
p2288 pRS416 GAL1-TDP-43-GFP (URA3) This study
GW1-DNAJB1pGW1-mApple [74]
pGW1-TDP43(A315T)-EGFP pGW1-DNAJB1 [74]
pGW1 pGW1-TDP43(A315T)-EGFP [74]
pGW1-EGFP pGW1 [74]
pGW1-EGFP [74]
https://doi.org/10.1371/journal.pgen.1006805.t002
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transformants of a PCR mcherry-HIS5 amplified fragment from p2268 from SD-His plates for
the Sis1-mCherry signal. In L3491, the nuclear marker HTB1 was mCherry tagged by trans-
forming L1749 with Cla1 linearized p2278 (pRS305-ADH1-HTB1-mCherry). Isogenic [pin-]
versions of strains were obtained on YPD plates with 5 mM GuHCl and were confirmed to be
[pin-] by checking for lack of aggregates after transforming with an Rnq1-GFP plasmid [90].
Unless otherwise stated, all overexpression plasmids were driven by GAL1. The TDP-43
entry clones (p2273 and p2367) were made by BP reactions between pDONR221 and a PCR
amplified TDP-43 fragment with (p2273) or without a stop codon (p2367) using Gateway
Technology [96] and the TDP-43 fragment in p2273 was further transferred to p2039, p2189
and p2245 to build p2055 (pAG426 GAL1-TDP43), p2275 (pAG414 GAL1-TDP43) and p2368
(pAG415-GAL1-TDP43), respectively. pDONR221-TDP-43 without stop codon (p2367) was
used as a donor plasmid to build pGAL1-TDP-43-DsRed (p2173) on a destination vector
(p2302). Plasmid p2195 (pAG413-GAL1-TDP43-EYFP) was constructed by a LR reaction
between pDONR221-TDP-43-EYFP (p2187) and p2186 (pAG413-GAL1-ccdB). Plasmid p2288
(pRS416 GAL1-TDP-43-GFP) was generated by switching TDP-43-YFP in p2042 (pRS416
GAL1-TDP43-YFP) with TDP-43-GFP from p2041 (pRS426 GAL1-TDP43-GFP).TET pro-
moter driven TDP-43-YFP (p2223) was constructed on pCM184, which was transformed into
a Gateway expression vector (p1576).
Cultivation procedures
Yeast strains were cultivated using standard media and growth conditions [97]. Rich media
contained 2% dextrose (YPD). Synthetic complete media contained all amino acids except for
those used for selection and 2% dextrose (SD); 2% glycerol (SG); 2% galactose (SGal); 2% raffi-
nose (SRaf) or 2% galactose + 2% raffinose (SGal/Raf). To avoid collecting suppressor mutants
that reversed TDP-43 toxicity, pGAL1-TDP-43 transformants were routinely plated and
patched on plasmid selective SD medium where TDP-43 was not expressed. Patches were then
replica-plated onto SG. Cells that failed to grow on SG were dropped from further study
because they were petites. For analysis of growth, non-petite transformants taken from SD
plates and suspended in water were normalized to an OD600 of 1.5. Then, 15 μl of 10X serially
diluted cell suspensions were spotted on plasmid selective SD and SGal.
Measuring cell death
Cells containing the pGAL1-TDP-43 or control plasmids grown overnight in selective SRaf
were resuspended and grown in SGal/Raf for 72 h to allow for TDP-43 overexpression. Then
cells were resuspended in 1/10th volume TE and 1.5 μl were mixed on slides with 1.5 μl of 0.4%
trypan blue. Different fields of the cells were then photograph under a Nikon Eclipse fluores-
cent microscope. The number of blue vs. unstained cells were counted blind. Between 820 and
1106 cells were counted for each sample.
Animal work
All vertebrate animal work was approved by the Committee on the Use and Care of Animals at
the University of Michigan (protocol # PRO00007096). All experiments were carefully planned
so that we use as few animals as possible. Pregnant female wild-type, non-transgenic Long
Evans rats (Rattus norvegicus) were housed singly in chambers equipped with environmental
enrichment. They were fed ad libitum a full diet (30% protein, 13% fat, 57% carbohydrate; full
information available at www.labdiet.com), and cared for by the Unit for Laboratory Animal
Medicine (ULAM) at the University of Michigan. Veterinary specialists and technicians in
ULAM are trained and approved in the care and long-term maintenance of rodent colonies, in
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accordance with the NIH-supported Guide for the Care and Use of Laboratory Animals. All
rats were kept in routine housing for as little time as possible prior to euthanasia and dissec-
tion, minimizing any pain and/or discomfort. Pregnant dams were euthanized by CO2 inhala-
tion at gestation day 20. For each animal, euthanasia was confirmed by bilateral
pneumothorax. Euthanasia was fully consistent with the recommendations of the Guidelines
on Euthanasia of the American Veterinary Medical Association and the University of Michi-
gan Methods of Euthanasia by Species Guidelines. Following euthanasia, the fetuses were
removed in a sterile manner from the uterus and decapitated. Primary cells from these fetuses
were dissected and cultured immediately afterwards.
Primary cortical neuron methods
Mixed primary cortical neurons were isolated from E20 rat pups as described previously [98]
and transiently transfected on day 4 in vitro (DIV4) with plasmids encoding TDP-43 variants,
DNAJB1, or siRNA targeting DNAJB1 (Dharmacon ON-TARGETplus Rat Dnajb1 (361384)
siRNA—SMARTpool) using Lipofectamine 2000 (Invitrogen) [74]. We then tracked neuronal
survival using a system of fully automated fluorescence microscopy [8,74,99]. Background was
digitally subtracted from raw images and the adjusted images were stitched together in Fiji.
Stitched images were sequenced and registered (aligned) using the multistackreg plugin in Fiji,
and neuron survival determined by custom-designed code written in Python. In this method
cell death is marked by disruption of the cell membrane, loss of neuronal processes, or round-
ing of the cell body. We plotted the cumulative risk of death for neurons in each population,
and compared survival between groups using Cox proportional hazards analysis. All statistical
analyses were performed in R using the survival analysis package.
Imaging was accomplished using a Nikon TiE-B inverted microscope equipped with Per-
fectFocus3, a high-numerical aperture 20X objective lens and a 16-bit Andor iXon electron
multiplied ultra-cooled charge-coupled device digital camera. A Lambda XL Xenon lamp (Sut-
ter) illuminated the samples via a 5-mm liquid light guide. All x- and y- stage movements were
performed using an ASI 2000 stage and rotary encoders. An environmental chamber that
maintained 37˚C and 5% CO2 was used for all experiments. All movements of the stage, shut-
ters, and PerfectFocus3 system were controlled by BeanShell code from μManager, publicly
available software that runs in ImageJ.
Immunocytochemistry
Rodent primary cortical neurons were isolated and transfected on DIV4 as described above.
Forty-eight hours later the cells were rinsed twice in PBS, then fixed in 4% paraformaldehyde
for 10 min. Following 2 more rinses, neurons were permeabilized with 0.1% Triton X-100 in
PBS for 20 min at room temperature, equilibrated with 10 mM glycine in PBS for 10 min at
room temperature, then blocked in 0.1% Triton X-100, 3% BSA and 0.2% goat serum in PBS
for 1 hour at room temperature. Primary antibodies against DNAJB1 (Abcam ab69402, rabbit
polyclonal anti-Hsp40, 1:100) were added directly to the block and the samples incubated
overnight at 4˚C. All cells were rinsed twice quickly and 3 times for 10 min with PBS, then
placed back in block solution containing the appropriate secondary antibodies (Donkey anti-
rabbit Cy5, Jackson ImmunoResearch, 711-175-152, whole IgG) at a dilution of 1:250. The
cells were rinsed twice quickly in PBS, and 3 times for 10 min each in PBS containing Hoescht
dye (33342, Invitrogen) at 100 nM, then twice more in PBS before imaging by automated
microscopy.
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Measuring protein levels
Equal amounts of total proteins in precleared lysates were analyzed by Western blot as
described previously [100]. To analyze TDP-43 aggregates on semi-denaturing Detergent
Agarose Gel electrophoresis (SDD-AGE) proteins were extracted from cells expressing
GAL1-controlled TDP-43-GFP [101,102]. Around 60 μg of crude lysate was treated with 2%
sarkosyl sample buffer (25 mM Tris, 200 mM glycine, 5% glycerol, and 0.025% bromophenol
blue) for 7 min at room temperature and electrophoretically resolved in a horizontal 1.5%
agarose gel in a standard tris/glycine/SDS buffer, transferred to a PVDF membrane and
probed with indicated antibodies. To visualized monomer TDP-43, the crude lysates were
boiled at 95˚C for 5 min in 2% SDS sample buffer containing 80 mM dithiothreitol (DTT)
prior to electrophoresis. Blots were developed with TDP-43 rabbit polyclonal antibody from
Proteintech Group (Rosemont, IL); Sis1 antibody kindly provided by E. Craig (Madison,
WI); Sup35C monoclonal antibody (made in our lab by Viravan Prapapanich). GFP and
PGK antibodies were purchased from Roche Applied Science (Indianapolis, IN) and Novex
(Frederick, MD), respectively.
To compare levels of proteins in supernatant vs. pellet, normalized cell lysates [103] (300 μl
at a concentration of 1 mg of protein /ml) were centrifuged at 90,000 rpm for 30 min at 4˚C to
separate supernatant and pellet fractions. After the supernatant was removed and saved, pellets
were washed with the lysate buffer containing a protease inhibitor cocktail, recentrifuged at
90,000 rpm for 10 min and resuspended in 300 μl of lysate buffer. Boiled proteins in total (T),
supernatant (S) and pellet (P) fractions were resolved by PAGE that was immunoblotted with
anti-TDP-43. The blots were then stripped and reprobed with anti-Sis1 and the loading control
anti-Pgk1.
Visualization of aggregates and co-localization studies
Aggregates formed in cells by fluorescently labeled proteins were examined with a Nikon
Eclipse E600 fluorescent microscope (100X oil immersion) equipped with FITC, YFP and
mCherry (respectively, chroma 49011, 49003 and 49008) filter cubes. Cells were sometimes
fixed with formaldehyde 3.7% final concentration for 15 minutes before washing with 0.1M
potassium phosphate (pH 7.5) and were imaged over the next few days (http://openwetware.
org/wiki/McClean:_Fixation_of_Yeast,Bisaria_Protocol)). Fixed and unfixed cells looked
identical in shape and GFP and mCherry fluorescence in control experiments. Cells were
always examined and photographed in the mCherry channel before being exposed to FITC
excitation and all experiments controlled for very bright GFP fluorescence that also appeared
in the mCherry channel even in the absence of an mCherry tag.
Immunocapture
Cells containing TDP-43-GFP (p2288) made after 24 h growth in SRaf/Gal-Ura medium to
induce TDP-43-GFP were harvested, and washed in ice cold water. As described previously
[100], lysates were made by vortexing 800 μl cells resuspended in LB2 buffer [40 mM Tris-HCl
(pH 7.5), 150 mM KCl, 5 mM MgCl2, 10% glycerol] containing anti-protease cocktail and
PMSF. Then 500 μl of the precleared lysate containing 0.5–1.0 mg/ml proteins were incubated
with 2 μl of TDP-43 antibody for 2 h on ice; samples were then mixed with 50 μl magnetic
beads with immobilized G protein (Miltenyi Biotec Inc., San Diego, CA) and incubated on ice
for 1 h. Nonspecifically bound proteins were removed in the following order of washing steps.
Beads were washed with 1.0 ml of each of the following solutions at room temperature: LB2
with 1% Triton X-100 with LB2, 210 mM KCl, 1% Triton X-100; LB2 with 1% Triton X- 100;
LB2; LB1 [40 mM Tris-HCl (pH 7.5), 50 mM KCl, 5 mM MgCl2, 5% glycerol]; 20 mM Tris-
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HCl (pH 7.6). Proteins were eluted with hot sample buffer (50 mM Tris-HCl, pH 6.8, 5% glyc-
erol, and 0.05 and 2% β-mercaptoethanol), and then they were analyzed by electrophoresis
and immunoblotting. Total (Input) protein was boiled at 95˚C for 5 min in 2% SDS sample
buffer containing 80 mM DTT.
Supporting information
S1 Fig. Comparison of growth inhibition caused by TDP-43 overexpression in the presence
of different toxicity modifiers (overexpression of Sis1, Hsp104, Pbp1, and hUpf1) in
[PIN+] and [pin-] versions of different yeast strains. [PIN+] and [pin-] versions of 74D-694,
W303 and BY4741 were doubly transformed with GAL1 controlled TDP-43-DsRed, GAL1
controlled modifier or control empty vector plasmids listed below. Transformants were
selected on SD-Leu-Ura plates. Normalized suspensions of cells taken from SD-Leu-Ura were
10X serially diluted in water and 15 μl were spotted on SD-Leu-Ura (dextrose), and 2% Gal-
Leu-Ura (galactose) plates, which were photographed after 3 (dextrose) or 5 (galactose) days of
incubation at 30˚C. We show hUpf1 because it had a bigger effect than the yeast homologue
Ecm32 found in the initial screen [64].
v/v: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/v: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/Sis1: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p1759 (GAL1-SIS1,URA3)
v/Sis1: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p1759 (GAL1-SIS1,URA3)
v/v: p2302 (pAG415 GAL1L-ccdB-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/v: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/Hsp104: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p1285 (GAL1-HSP104,
URA3)
v/Hsp104: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p1285 (GAL1-HSP104,URA3)
v/v: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/v: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/hUpf1: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p2292 (GAL1-hUpf1, URA3)
v/hUpf1: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p2292 (GA1L-hUpf1, URA3)
v/v: p2245 (pAG415 GAL1-ccdB, LEU2) / p484 (GAL1, URA3)
TDP-43/v: p2368 (pAG415 GAL1-TDP-43, LEU2) / p484 (GAL1, URA3)
TDP-43/hUpf1: p2368 (pAG415 GAL1-TDP-43, LEU2) / p2292 (GAL1-hUpf1, URA3)
TDP-43/Sis1: p2368 (pAG415 GAL1-TDP-43, LEU2) / p1759 (GAL1-SIS1,URA3)
v/v: p2302 (pAG415 GAL1-ccdB-DsRed, LEU2) / p484 (GAL1, URA3)
TDP-43/v: p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p484 (GAL1, URA3)TDP-43/Pbp1:
p2173 (pAG415 GAL1-TDP-43-DsRed, LEU2) / p2228 (GAL1-PBP1, URA3)
(PDF)
S2 Fig. Overexpression of TDP-43 causes elongated cell shape. [PIN+] and [pin-] versions of
74D-694 (A), BY4741 (B) and W303 (C) carrying pGAL1-TDP-43-DsRed (p2173) or pAG415
GAL1-ccdB-DsRed (p2302) were grown on 2% galactose plates for 4 days and then imaged at
the same magnification. Shown are representative fields of many fields photographed and
examined.
(PDF)
S3 Fig. Cell elongation is associated with TDP-43 protein levels. Transformants of [pin-]
74D-694 with pTETR-TDP-43-YFP (p2223) were selected on SD-Trp supplemented with doxy-
cycline (10 μg/ml). Transformants were then grown in liquid SGal-Trp media with the indi-
cated amount of doxycycline for 24 h and were examined and photographed at same
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magnification. The levels of TDP-43-YFP were determined by immunoblotting SDS-PAGE
gels of normalized cell lysates probed with anti-TDP-43 antibodies, and anti-Pgk1 antibodies
as an internal loading control.
(PDF)
S4 Fig. Sis1 overexpression does not cure cells of [PIN+]. [PIN+] and [pin-] 74D-694 dou-
bly transformed with pGAL1-TDP-43-DsRed (p2173) and pGAL-Sis1 (p1759) were grown in
plasmid selective synthetic liquid media containing 2% galactose and 2% raffinose for 2
days. Cells were then crossed to [pin-] 64D-694 MATα (L2642) bearing plasmid p1185
(pCUP1-RNQ1-GFP). Diploids were selected on SD-Leu-Ura-Trp, expressed on SD-Leu-
Ura-Trp supplemented with Cu++ (50 μg/ml), and examined for Rnq1-GFP dots or diffuse
fluorescence, which was diagnostic for the presence or absence, respectively, of the [PIN+]
prion.
(PDF)
S5 Fig. Alteration of Hsp104 and Ssa1 levels does not affect ability of Sis1 overexpression
to reduce TDP-43 toxicity. A. Deletion of HSP104 does not prevent Sis1 overexpression from
reducing TDP-43 toxicity. Isogenic [psi-] [pin-] versions of 74D-694 with (hsp104Δ) and with-
out (WT) a deletion of HSP104 doubly transformed with p2042 (pGAL1-TDP-43-YFP) and
p1767 (pGAL1-SIS1) or vector control p1752 (pGAL1-YFP) and p1768 (pGAL1) were selected
on SD-Ura-Trp plates. Normalized suspensions of cells taken from SD-Ura-Trp were 10X seri-
ally diluted in water and 15 μl were spotted on SD-Ura-Trp (dextrose), and 2% SGal-Ura-Trp
(galactose) plates which were photographed after 3 (dextrose) or 7 (galactose) days of incuba-
tion at 30˚C. B. Reduction of Ssa1 activity does not prevent Sis1 overexpression from reducing
TDP-43 toxicity. Strain 1014 bearing a deletion of SSA2 and expressing a dominant negative
allele of SSA1 (SSA1-21 ssa2Δ) and its isogenic parent strain, L3504 (WT) were doubly trans-
formed with pGAL1-TDP-43-DsRed (p2173), pGAL-SIS1 (p1759), or vector controls (p2302 or
p484). Normalized suspensions of cells taken from plasmid selective SD-Leu-Ura medium
were 10X serially diluted in water and 15 μl were spotted on SD-Leu-Ura (dextrose), and 2%
Gal-Leu-Ura (galactose) plates, which were photographed after 3 (dextrose) or 5 (galactose)
days of incubation at 30˚C.
(PDF)
S6 Fig. DNAJB1 deficiency does not exacerbate TDP-43 toxicity. Rodent primary cortical
neurons were dissected and transfected with plasmids encoding EGFP and TDP-43(WT)-
mApple or mApple. In each case, neurons were also transfected with scrambled siRNA or
siRNA targeting DNAJB1. (A) Knockdown was validated by immunocytochemistry using
antibodies against DNAJB1. Scale bar, 50 μm. (B) Transfection with siRNA against DNAJB1
resulted in a 60% reduction in anti-DNAJB1 antibody reactivity (N = 101 and 62 neurons
from Scr and siDNAJB1, respectively.  p< 0.0001 by the Mann—Whitney U test. (C) In lon-
gitudinal assays of neuronal survival, DNAJB1 knockdown enhanced the risk of death by 20%
in control neurons expressing EGFP alone and in neurons overexpressing TDP43.  HR 1.20,
p 0.004;  HR 1.21, p 2.3x10-5; # HR 3.18, p< 2x10-16, Cox proportional hazards analysis.
Results were pooled from two independent experiments.
(PDF)
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